"When the first polls closed, we started to see massive U.S. buying and it just hasn't stopped since," said McCann, founder of crypto-focused hedge fund Asymmetric. "The sentiment in the crypto ...

Bayer is now going to conduct Phase 3 clinical trials for obstructive HCM in Japan, while Cytokinetics will expand its ongoing ACACIA-HCM and CEDAR-HCM trials into Japan.